Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study

PURPOSE: This study aimed to evaluate the efficacy and safety of neoadjuvant programmed cell death-1 (PD-1) inhibitors plus apatinib and chemotherapy (PAC) in patients with locally advanced gastric cancer (LAGC). MATERIALS AND METHODS: Seventy-three patients with resectable LAGC were enrolled and na...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chunjing, Wang, Zhen, Zhao, Yue, Wang, Fujing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154141/
https://www.ncbi.nlm.nih.gov/pubmed/37129156
http://dx.doi.org/10.5230/jgc.2023.23.e17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154141/
https://www.ncbi.nlm.nih.gov/pubmed/37129156
http://dx.doi.org/10.5230/jgc.2023.23.e17

Ejemplares similares